Annual report
4188.TEDINET S100R4IA
Period2022-04-01 → 2023-03-31
Filed2023-06-27
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Amended by S100SN75 (2024-01-19).
Key figures · 160
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.63T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥3.26T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.58T | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.84T | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥182.7bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥303.2bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥168.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥32.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥122.0bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥284.8bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥96.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥7.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥54.1bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥169.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥135.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥22.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥86.6bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥216.7bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥5.77T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.57T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.29T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.13T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥5.57T | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.79T | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.73T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.99T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.57T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.56T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.24T | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.17T | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.38T | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥297.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥228.2bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥321.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥355.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥467.1bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥452.0bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥415.6bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥247.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥217.0bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥87.6bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥895.1bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥60.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥142.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥450.5bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥519.1bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥67.57 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-5.32 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥38.08 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥119.22 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥64.72 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-5.32 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥35.21 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥110.05 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,100.04 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,026.03 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥870.4 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥824.07 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥970.46 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 27.1% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 23.4% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 22.8% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.7% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 6.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 13.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -0.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 12.7% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 68,639 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 69,784 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 69,607 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 69,609 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 72,020 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥125.3bn | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥69.5bn | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥24.7bn | 2020-04-01 → 2021-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥71.6bn | 2019-04-01 → 2020-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥108.6bn | 2018-04-01 → 2019-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥106.0bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥55.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥103.1bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥52.6bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥10.4bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥58.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥97.6bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥104.0bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥54.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥104.5bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥56.2bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥11.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥30.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥98.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.01T | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥1.80T | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥1.99T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.92T | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.62T | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.54T | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.39T | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥471.4bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥409.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥392.3bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥413.4bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥441.0bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥46.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥332m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥73.51 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.56 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.37 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.19 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.34 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥70.41 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.62 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥7.87 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.67 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.09 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥32 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥329.8 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥286.54 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥273.62 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥288.5 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥307.93 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 23.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 23.9% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.1% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 23.2% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,506,288,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,506,288,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 430 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 223 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 201 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 166 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 149 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 99
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥3.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 7538 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥425.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥226.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥199.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥268.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥16.5bn |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥308.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥308.5bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥439.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥14.5bn |
| Chemicalsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥65.4bn |
| Chemicalsreportable segment | employees | at 2023-03-31 | 7436 pure |
| Chemicalsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.48T |
| Chemicalsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.43T |
| Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥49.5bn |
| Chemicalsreportable segment | segment assets | at 2023-03-31 | ¥1.21T |
| Chemicalsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥9.2bn |
| Health Carereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥29.6bn |
| Health Carereportable segment | employees | at 2023-03-31 | 6468 pure |
| Health Carereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥547.6bn |
| Health Carereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥547.1bn |
| Health Carereportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥416m |
| Health Carereportable segment | segment assets | at 2023-03-31 | ¥1.04T |
| Health Carereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥141.8bn |
| Industrial Gasesreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥96.6bn |
| Industrial Gasesreportable segment | employees | at 2023-03-31 | 19586 pure |
| Industrial Gasesreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.19T |
| Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.18T |
| Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥8.8bn |
| Industrial Gasesreportable segment | segment assets | at 2023-03-31 | ¥2.22T |
| Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥121.0bn |
| Performance Productsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥82.0bn |
| Performance Productsreportable segment | employees | at 2023-03-31 | 26385 pure |
| Performance Productsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.30T |
| Performance Productsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.25T |
| Performance Productsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥50.6bn |
| Performance Productsreportable segment | segment assets | at 2023-03-31 | ¥1.47T |
| Performance Productsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥51.5bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥273.6bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥4.52T |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥4.41T |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥109.3bn |
| —segment total | segment assets | at 2023-03-31 | ¥5.95T |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥323.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥277.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥4.94T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥4.63T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥308.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥6.21T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥340.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥404.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥198.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥205.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥270.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥15.0bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥26.9bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥309.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥309.2bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | −¥507.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥15.5bn |
| Chemicalsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥61.3bn |
| Chemicalsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.33T |
| Chemicalsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.29T |
| Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥43.8bn |
| Chemicalsreportable segment | segment assets | at 2022-03-31 | ¥1.29T |
| Chemicalsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥102.2bn |
| Health Carereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Health Carereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥404.0bn |
| Health Carereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥403.6bn |
| Health Carereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥410m |
| Health Carereportable segment | segment assets | at 2022-03-31 | ¥1.07T |
| Health Carereportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥7.0bn |
| Industrial Gasesreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥74.7bn |
| Industrial Gasesreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥957.1bn |
| Industrial Gasesreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥950.1bn |
| Industrial Gasesreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Industrial Gasesreportable segment | segment assets | at 2022-03-31 | ¥2.04T |
| Industrial Gasesreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥98.9bn |
| Performance Productsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥68.7bn |
| Performance Productsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.19T |
| Performance Productsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.14T |
| Performance Productsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥52.5bn |
| Performance Productsreportable segment | segment assets | at 2022-03-31 | ¥1.41T |
| Performance Productsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥78.7bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥224.2bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥3.88T |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥3.78T |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥103.7bn |
| —segment total | segment assets | at 2022-03-31 | ¥5.81T |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥272.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥227.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥4.29T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥3.98T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥309.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥6.08T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥287.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,351
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00808-000IndustrialGasesReportableSegmentMember | 3500000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00808-000HealthCareReportableSegmentMember | 90700000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 200000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration_jpcrp030000-asr_E00808-000PerformanceProductsReportableSegmentMember | 68652000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00808-000PerformanceProductsReportableSegmentMember | 82024000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration_jpcrp030000-asr_E00808-000ChemicalsReportableSegmentMember | 61344000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00808-000ChemicalsReportableSegmentMember | 65365000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration_jpcrp030000-asr_E00808-000IndustrialGasesReportableSegmentMember | 74661000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00808-000IndustrialGasesReportableSegmentMember | 96636000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration_jpcrp030000-asr_E00808-000HealthCareReportableSegmentMember | 19504000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00808-000HealthCareReportableSegmentMember | 29602000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3539000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3374000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration_CorporateSharedMember | 26889000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 5172000000 | JPY |
| Capital expenditures overview of capital expenditures etc | Prior1YearDuration | 254589000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 282173000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1506288107 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1506288107 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1506288107 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1506288107 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | 2 | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 163 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 80 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 1915 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 745 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 339 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 280397 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 283641 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | 50 | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 5530323 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 521394 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 455697 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 4695352 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 7469 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 3825176 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 15035461 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 2742007 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | 0.0000 | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.3678 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0347 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.0303 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.3123 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0005 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.2544 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 224331000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1575 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 148370000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.1042 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |